| [1] |
Crane G M, Ishaug S L, Mikos A G.Bone tissue engineering[J].Nat. Med, 1995, 1:1322-4.
|
| [2] |
Sudo K, Kanno M, Miharada K, et al.Erratum to: Mesenchymal Progenitors Able to Differentiate into Osteogenic,Chondrogenic,andor Adipogenic Cells In Vitro Are Present in Most Primary Fibroblast‐Like Cell Populations[J].Stem Cells, 2010, 25(7):1610-1617
|
| [3] |
Veyrat-Masson R, Boiret-Dupré N, Rapatel C, et al.Mesenchymal content of fresh bone marrow: a proposed quality control method for cell therapy[J].British Journal of Haematology, 2010, 139(2):312-320
|
| [4] |
Méndez-Ferrer Simón, Michurina Tatyana V, Ferraro Francesca, et al.Mesenchymal and haematopoietic stem cells form a unique bone marrow niche[J].Nature, 2010, 466:829-34.
|
| [5] |
Liu H, Li W, Liu Y, et al.Co-administration of aspirin and allogeneic adipose-derived stromal cells attenuates bone loss in ovariectomized rats through the anti-inflammatory and chemotactic abilities of aspirin[J].Stem Cell Research & Therapy, 2015, 6(1):200-
|
| [6] |
姜蔚然, 张晓, 刘云松等.骨形态发生蛋白--磷酸钙共沉淀支架与人脂肪间充质干细胞构建新型组织工程化骨[J].北京大学学报医学版, 2017, 49(1):6-10
|
| [7] |
Xie X, Fu Y, Liu J.Chemical reprogramming and transdifferentiation[J]. Current Opinion in Genetics & Development, 2017, 46:104-113.
|
| [8] |
Keeler A M, ElMallah M K, Flotte T R.Gene Therapy 2017: Progress and Future Directions[J]. ClinTransl Sci, 2017, 10:242-248.
|
| [9] |
Liu Jie, Zhu Li-Ping, Yang Xu-Li, et al.HMG-CoA reductase inhibitors (statins) and bone mineral density: a meta-analysis[J]. Bone, 2013, 54:151-156.
|
| [10] |
Moraschini V, Almeida D C F, Calasans-Maia J A, et al.The ability of topical and systemic statins to increase osteogenesis around dental implants: A systematic review of histomorphometric outcomes in animal studies[J].International Journal of Oral and Maxillofacial Surgery, 2018, 47(8):1070-1078
|
| [11] |
Cristina A M, Alessandro D, Antonio O, et al.COX inhibitors and bone: A safer impact on osteoblasts by NO-releasing NSAIDs[J].Life Sciences, 2018, 208:10-19.
|
| [12] |
Cristina A M, Alessandro D, Antonio O, et al.COX inhibitors and bone: A safer impact on osteoblasts by NO-releasing NSAIDs[J].Life Sciences, 2018, 208:10-19.
|
| [13] |
Liu H, Li W, Liu Y, et al.Co-administration of aspirin and allogeneic adipose-derived stromal cells attenuates bone loss in ovariectomized rats through the anti-inflammatory and chemotactic abilities of aspirin[J].Stem Cell Research & Therapy, 2015, 6(1):200-
|
| [14] |
Ren L, Pan S, Li H, et al.Effects of aspirin-loaded graphene oxide coating of a titanium surface on proliferation and osteogenic differentiation of MC3T3-E1 cells[J]. Scientific Reports, 2018, 8(1).
|
| [15] |
L Lindh-?strand, M Hoffmann, L.J?rvstr?t,et alHormone therapy might be underutilized in women with early menopause[J].Human Reproduction, 2015, 30(4):848-52
|
| [16] |
Marzia F, Francesco C, Paola M, et al.Ferutinin dose-dependent effects on uterus and mammary gland in ovariectomized rats[J].Histology & Histopathology, 2014, 29(8):1027-37
|
| [17] |
Dong W, Chris S, Zuyong W, et al.Beta-Cyclodextrin Modified Mesoporous Bioactive Glass Nanoparticles/Silk Fibroin Hybrid Nanofibers as an Implantable Estradiol Delivery System for the Potential Treatment of Osteoporosis[J].Nanoscale, 2018, 10:18341-18353.
|
| [18] |
Song N, Zhi-Min Wang, Li-Juan He, et al.Estradiol-enhanced osteogenesis of rat bone marrow stromal cells is associated with the JNK pathway[J].Molecular Medicine Reports, 2017, 16(6):8589-8594
|
| [19] |
Brunetti G, Posa F, Mori G, et al.Vitamin D Promotes MSC Osteogenic Differentiation Stimulating Cell Adhesion andαVβ3 Expression[J].Stem Cells International, 2018, 2018(2):1-9
|
| [20] |
Wang D, Song J, Ma H.An in vitro Experimental Insight into the Osteoblast Responses to Vitamin D3 and Its Metabolites[J]. Pharmacology, 2018:225-235.
|
| [21] |
Bird A.Perceptions of epigenetics[J].Nature, 2007, 447(7143):396-8
|
| [22] |
Miranda T B, Jones P A.DNA methylation: the nuts and bolts of repression[J].Journal of Cellular Physiology, 2010, 213(2):384-390
|
| [23] |
Jenuwein T, Allis C D.Translating the histone code.[J]. Science, 2001, 293: 1074-80.
|
| [24] |
Kouzarides T.Chromatin Modifications and Their Function[J].Cell, 2007, 128(4):0-705
|
| [25] |
Wolf S S.The protein arginine methyltransferase family: an update about function,new perspectives and the physiological role in humans[J].Cellular & Molecular Life Sciences, 2009, 66(13):2109-2121
|
| [26] |
Cameron E E, Bachman K E, My?h?nenS, et al.Synergy of demethylation and histone deacetylase inhibition in the re-expression of genes silenced in cancer[J].Nature Genetics, 1999, 21(1):103-107
|
| [27] |
Garcia-Manero G, Assouline S, Cortes J, et al.Phase 1 study of the oral isotype specific histone deacetylase inhibitor MGCD0103 in leukemia[J].Blood, 2015, 112(4):981-
|
| [28] |
Huang H, Dou L, Song J, et al.CBFA2T2 is required for BMP-2-induced osteogenic differentiation of mesenchymal stem cells[J].Biochemical and Biophysical Research Communications, 2018, 496(4):1095-1101
|
| [29] |
Marmorstein R, Trievel R C.Histone modifying enzymes: Structures,mechanisms,and specificities[J].BiochimBiophys Acta, 2009, 1789(1):0-68
|
| [30] |
Ding Z, Yi-Xuan C, Jun-Hui Y, et al.Valproic acid prevents glucocorticoid-induced osteonecrosis of the femoral head of rats[J]. International Journal of Molecular Medicine, 2018, 41: 3433-3447.
|
| [31] |
Cantley M.D, Zannettino A C W, Bartold P M, et al. Histone deacetylases (HDAC) in physiological and pathological bone remodelling[J]. Bone, 2017, 95:162-174.
|
| [32] |
Brehove M, Wang T, North J, et al.Histone Core Phosphorylation Regulates DNA Accessibility[J].Journal of Biological Chemistry, 2015, 290(37):22612-21
|
| [33] |
Latham J A, Dent S Y R.Cross-regulation of histone modifications[J].Nature Structural & Molecular Biology, 2007, 14(11):1017-1024
|
| [34] |
Rossetto D, Avvakumov N, J C?t.Histone phosphorylation: a chromatin modification involved in diverse nuclear events[J].Epigenetics, 2012, 7(10):1098-1108
|
| [35] |
Li Ping, Yang Y M, Sanchez S, et al.Deubiquitinase MYSM1 Is Essential for Normal Bone Formation and Mesenchymal Stem Cell Differentiation[J].Scientific Reports, 2016, 6(22211):22211-
|
| [36] |
Masato Y, Hidefumi F, Masashi S, et al.Tumor necrosis factor alpha represses bone morphogenetic protein (BMP) signaling by interfering with the DNA binding of Smads through the activation of NF-kappaB[J].Journal of Biological Chemistry, 2009, 284(51):35987-95
|
| [37] |
Vimalraj S, Selvamurugan N.MicroRNAs expression and their regulatory networks during mesenchymal stem cells differentiation toward osteoblasts[J].International Journal of Biological Macromolecules, 2014, 66(4):194-202
|
| [38] |
Collino F, Bruno S, Deregibus M C, et al.MicroRNAs and Mesenchymal Stem Cells[J].Vitamins & Hormones-advances in Research & Applications, 2011, 87(87):291-320
|
| [39] |
Zhang J, Li Z, Wang H, et al.Ultrasensitive quantification of mature microRNAs by real-time PCR based on ligation of a ribonucleotide-modified DNA probe[J].Chemical Communications, 2011, 47(33):9465-9467
|
| [40] |
Dai Z, Jin Y, Zheng J, et al.MiR-217 promotes cell proliferation and osteogenic differentiation of BMSCs by targeting DKK1 in steroid-associated osteonecrosis[J]. Biomed. Pharmacother., 2019, 109:1112-1119.
|
